TetraLogic Pharmaceuticals Corp (TLOG)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Tony Meehan
Employees:
29
P.O. BOX 1305, PAOLI, NY 19301
610-889-9900

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development: Birinapant, and SHAPE. Birinapant is designed to mimic the activity of an endogenous protein, the Second Mitochondrial Activator of Caspases, which is involved in the regulation of the apoptotic process within cells. SHAPE is a histone deacetylase inhibitor that the company is developing for topical use for the treatment of cancer. The company was founded by John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.

Data derived from most recent annual or quarterly report
Market Cap 445.843 Thousand Shares Outstanding24.769 Million Avg 30-day Volume 24.429 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.07
Price to Revenue0.0 Debt to Equity-1.2999 EBITDA-35.981 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value38.233 Million
Current Ratio0.478 EPS Growth0.208 Quick Ratio0.441
1 Yr BETA -0.1339 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth35.4704 Altman Z-Score-9.5597 Free Cash Flow to Firm -23.641 Million
View SEC Filings from TLOG instead.

View recent insider trading info

Funds Holding TLOG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TLOG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROBINS DAVID C.

3,000,000 2017-09-15 0

NOMURA SECURITIES INTERNATIONAL, INC.

NOMURA HOLDINGS INC

  • SEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

HIGHBRIDGE CAPITAL MANAGEMENT LLC

  • SEE REMARKS
No longer subject to file 2016-11-14 0

TELEMETRY SECURITIES, L.L.C.

  • SEE REMARKS
No longer subject to file 2016-11-14 0

LAZARD ASSET MANAGEMENT LLC

  • SEE REMARKS
No longer subject to file 2016-11-14 0

WHITEBOX ADVISORS LLC

WHITEBOX GENERAL PARTNER LLC

WHITEBOX RELATIVE VALUE PARTNERS, L.P.

WHITEBOX MULTI-STRATEGY PARTNERS LP

PANDORA SELECT PARTNERS, L.P.

WHITEBOX GT FUND, LP

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

LINDEN ADVISORS LP

LINDEN CAPITAL L.P.

  • SEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

GEODE CAPITAL MANAGEMENT LP

  • SEE REMARKS
No longer subject to file 2016-11-14 0

HUDSON BAY CAPITAL MANAGEMENT LP

GERBER SANDER

  • SEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

STATE OF NEW JERSEY COMMON PENSION FUND D

  • SEE REMARKS
No longer subject to file 2016-11-14 0

HUTCHISON PATRICK CFO & TREASURER

  • Officer
7,000 2016-04-30 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
No longer subject to file 2016-02-08 0

PECORA ANDREW L

  • Director
184,830 2015-07-10 0

SCHMITT PAUL J

  • Director
1,542,962 2015-07-02 0

MEYERS PETE A. CFO & TREASURER

  • Officer
153,891 2015-03-27 0

BUCHI J KEVIN PRESIDENT & CEO

  • Officer
  • Director
330,714 2015-03-26 0

KISHBAUCH MICHAEL D

  • Director
0 2015-01-28 0

STEINMETZ MICHAEL

  • Director
0 2015-01-28 0

GRAY MARY ANN

  • Director
0 2015-01-28 0

ONSI DOUGLAS E

  • Director
0 2015-01-28 0

REED DOUGLAS MD

  • Director
0 2015-01-28 0

RUSSELL LESLEY CHIEF OPERATING OFFICER

  • Officer
0 2015-01-28 0

WOODY JAMES N.

  • Director
0 2015-01-28 0

SHERMAN RICHARD L. SEE REMARKS

  • Officer
0 2015-01-28 0

BEGLEY COLIN GLENN CHIEF SCIENTIFIC OFFICER & SVP

  • Officer
0 2015-01-28 0

AMGEN INC

AMGEN VENTURES LLC

  • 10% Owner
No longer subject to file 2013-12-17 0

HEALTHCARE VENTURES VII LP

HEALTHCARE PARTNERS VII, L.P.

LAWLOR AUGUSTINE

LITTLECHILD JOHN W

MIRABELLI CHRISTOPHER

ONSI DOUGLAS E

WERNER HAROLD R

CAVANAUGH JAMES H

  • Director
  • 10% Owner
2,586,466 2013-12-17 0

GAVIN BRENDA D

  • Director
948,268 2013-12-17 0

GILL JOHN

  • Director
40,312 2013-12-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 22:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 21:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 21:15:04 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 20:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 20:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 19:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 19:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 18:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 18:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 17:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 17:15:04 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 16:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 16:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 15:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 15:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 14:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 14:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 13:45:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 13:15:03 UTC -7.9801 8.0501 300000
TETRALOGIC PHARMACEUTICALS C TLOG 2022-01-19 12:45:03 UTC -7.9801 8.0501 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments